Feasibility and limitations of cultured skin fibroblasts for germline genetic testing in hematologic disorders.

Authors:
DeRoin L; Cavalcante de Andrade Silva M; Petras K; Arndt K; Phillips N and 12 more

Journal:
Hum Mutat

Publication Year: 2022

DOI:
10.1002/humu.24374

PMCID:
PMC9177640

PMID:
35419889

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Hum Mutat

Abbreviation: Hum Mutat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advances in the development of PubCaseFinder, including the new application programming interface a…
Fujiwara T; Shin JM; Yamaguchi A. (2022) - Transparency Score: 3/6
Beacon v2 and Beacon networks: A "lingua franca" for federated data discovery in biomedical genomic…
Rambla J; Baudis M; Ariosa R and 12 more (2022) - Transparency Score: 3/6
Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in th…
Chen SX; Simpson E; Reiter JL and 1 more (2022) - Transparency Score: 3/6
Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form-associated genes …
Goudal A; Karakachoff M; Lindenbaum P and 19 more (2022) - Transparency Score: 4/6
Clinical exome sequencing-Mistakes and caveats.
Corominas J; Smeekens SP; Nelen MR and 4 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST The authors report the following conflicts of interest: Honoraria for an educational article, UpToDate, Inc. (J. E. C. and L. A. G.)."

Evidence found in paper:

"The authors would like to thank all of the patients who participated in this study and James P. Zacny, Ph.D. for editorial assistance. Funding sources that supported this study were the American Society of Hematology (Minority Medical Student Award Program [L. D.]), the National Heart, Lung, and Blood Institute (R25HL096383‐09 [L. D.]) and R03 HL145253 [J. E. C.), and CAPES/PDSE/8888.1/188484/2018‐01 (M. C. A. S.)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025